Allogene Therapeutics
South San Francisco, CA
Allogene Therapeutics, Inc. operates as a biotechnology company. The Company develops allogeneic chimeric antigen receptor T-cell therapy for the treatment of blood cancers and solid tumors. Allogene Therapeutics serves patients in the State of California.
allogene.comCompany Details
Founded
- 2017
Employees
- Between 200 - 500 employees
Raised
- $531,770,400
Headquarters Location
- South San Francisco, CA
Public
- Yes
Acquired
- No
CEO
- David D Chang
Founders
- David Chang
Company Collections
These are collections Allogene Therapeutics is a part of. Click on the collection name to view similar companies.